You are here

Nat Neurosci DOI:10.1038/s41593-018-0154-9

A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease.

Publication TypeJournal Article
Year of Publication2018
AuthorsMostafavi, S, Gaiteri, C, Sullivan, SE, White, CC, Tasaki, S, Xu, J, Taga, M, Klein, H-U, Patrick, E, Komashko, V, McCabe, C, Smith, R, Bradshaw, EM, Root, DE, Regev, A, Yu, L, Chibnik, LB, Schneider, JA, Young-Pearse, TL, Bennett, DA, De Jager, PL
JournalNat Neurosci
Date Published2018 Jun

There is a need for new therapeutic targets with which to prevent Alzheimer's disease (AD), a major contributor to aging-related cognitive decline. Here we report the construction and validation of a molecular network of the aging human frontal cortex. Using RNA sequence data from 478 individuals, we first build a molecular network using modules of coexpressed genes and then relate these modules to AD and its neuropathologic and cognitive endophenotypes. We confirm these associations in two independent AD datasets. We also illustrate the use of the network in prioritizing amyloid- and cognition-associated genes for in vitro validation in human neurons and astrocytes. These analyses based on unique cohorts enable us to resolve the role of distinct cortical modules that have a direct effect on the accumulation of AD pathology from those that have a direct effect on cognitive decline, exemplifying a network approach to complex diseases.


Alternate JournalNat. Neurosci.
PubMed ID29802388
Grant ListP30 AG010161 / AG / NIA NIH HHS / United States
R01 AG017917 / AG / NIA NIH HHS / United States
R01 AG057911 / AG / NIA NIH HHS / United States